Antibiotics, Antineoplastic

"Antibiotics, Antineoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.

Descriptor ID	D000903
MeSH Number(s)	D27.505.954.248.106
Concept/Terms	Antibiotics, Antineoplastic Antibiotics, Antineoplastic Antineoplastic Antibiotics Antibiotics, Cytotoxic Antibiotics, Cytotoxic Cytotoxic Antibiotics

Below are MeSH descriptors whose meaning is more general than "Antibiotics, Antineoplastic".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Antineoplastic Agents [D27.505.954.248]
Antibiotics, Antineoplastic [D27.505.954.248.106]

Below are MeSH descriptors whose meaning is related to "Antibiotics, Antineoplastic".

Below are MeSH descriptors whose meaning is more specific than "Antibiotics, Antineoplastic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antibiotics, Antineoplastic" by people in this website by year, and whether "Antibiotics, Antineoplastic" was a major or minor topic of these publications.

Bar chart showing 46 publications over 22 distinct years, with a maximum of 5 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1999	0	1	1
2001	0	1	1
2003	2	0	2
2004	1	1	2
2005	1	1	2
2006	2	3	5
2007	3	1	4
2008	0	1	1
2009	1	1	2
2010	1	1	2
2012	1	3	4
2013	2	1	3
2014	1	0	1
2015	0	4	4
2016	1	1	2
2017	1	0	1
2018	2	0	2
2020	3	0	3
2023	0	1	1
2024	0	1	1
2025	0	1	1

Below are the most recent publications written about "Antibiotics, Antineoplastic" by people in Profiles.

Mondal T, Sahoo P, Nandi SK, Kundu S, Li M, Haldar N, Kabir R, Mitra K, Roy S, Das M, Ghosh CK. Opto-magnetic optimization enhances the multimodal therapeutic and diagnostic (UCL/T1-T2W MRI) potential of GdOF against MDA-MB-231. J Mater Chem B. 2025 Aug 13; 13(32):9993-10008.

View in: PubMed
Xia WF, Zheng XL, Liu WY, Huang YT, Wen CJ, Zhou HH, Wu QC, Wu LX. Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway. Cancer Gene Ther. 2024 May; 31(5):778-789.

View in: PubMed
Huang X, Fan XY, Cheng Q, Zhang J, Sun J, Tang QY, Deng YB, Bi XJ. Intrinsic Wave Velocity Propagation: A Novel Parameter for Assessing the Effect of Anthracycline Chemotherapy Agents on Cardiac Diastolic Function in Breast Cancer Patients. Curr Med Sci. 2023 Dec; 43(6):1229-1237.

View in: PubMed
Sapkota Y, Qin N, Ehrhardt MJ, Wang Z, Chen Y, Wilson CL, Estepp J, Rai P, Hankins JS, Burridge PW, Jefferies JL, Zhang J, Hudson MM, Robison LL, Armstrong GT, Mulrooney DA, Yasui Y. Genetic Variants Associated with Therapy-Related Cardiomyopathy among Childhood Cancer Survivors of African Ancestry. Cancer Res. 2021 05 01; 81(9):2556-2565.

View in: PubMed
Chowdhury N, Chaudhry S, Hall N, Olverson G, Zhang QJ, Mandal T, Dash S, Kundu A. Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment. AAPS PharmSciTech. 2020 Jul 21; 21(6):202.

View in: PubMed
Loyola AC, Dao K, Shang R, Zhang L, Dutta P, Fowler C, Li J, Li WX. Streptonigrin at low concentration promotes heterochromatin formation. Sci Rep. 2020 02 26; 10(1):3478.

View in: PubMed
Khan H, Chaudhary JP, Meena R. Anionic carboxymethylagarose-based pH-responsive smart superabsorbent hydrogels for controlled release of anticancer drug. Int J Biol Macromol. 2019 Mar 01; 124:1220-1229.

View in: PubMed
Miles JS, Sojourner SJ, Whitmore AM, Freeny D, Darling-Reed S, Flores-Rozas H. Synergistic Effect of Endogenous and Exogenous Aldehydes on Doxorubicin Toxicity in Yeast. Biomed Res Int. 2018; 2018:4938189.

View in: PubMed
Kutlehria S, Behl G, Patel K, Doddapaneni R, Vhora I, Chowdhury N, Bagde A, Singh M. Cholecalciferol-PEG Conjugate?Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer. AAPS PharmSciTech. 2018 Feb; 19(2):792-802.

View in: PubMed
Mukhopadhyay S, Frias MA, Chatterjee A, Yellen P, Foster DA. The Enigma of Rapamycin Dosage. Mol Cancer Ther. 2016 Mar; 15(3):347-53.

View in: PubMed

People

Explore

Similar Concepts

Top Journals